A multicenter retrospective cohort study on predicting the risk for amiodarone pulmonary toxicity.
| dc.contributor.author | Kwok, Wang Chun | |
| dc.contributor.author | Ma, Ting Fung | |
| dc.contributor.author | Chan, Johnny Wai Man | |
| dc.contributor.author | Pang, Herbert H | |
| dc.contributor.author | Ho, James Chung Man | |
| dc.date.accessioned | 2024-03-31T17:33:49Z | |
| dc.date.available | 2024-03-31T17:33:49Z | |
| dc.date.issued | 2022-04 | |
| dc.description.abstract | BackgroundAmiodarone is one of the most commonly used anti-arrhythmic agents. Amiodarone pulmonary toxicity is a potentially fatal adverse effect associated with amiodarone use. Previous studies on the epidemiology and risk factors for amiodarone pulmonary toxicity showed diverse results.MethodsA multicenter retrospective cohort study was conducted to identify clinic-epidemiologic markers associated with amiodarone pulmonary toxicity for development of a prediction rule. Patients taking amiodarone who were managed in 3 centres in Hong Kong from 2005 to 2015 were included in this study. Penalized logistic regression was used to model the outcome as it is rare.ResultsA total of 34 cases with amiodarone pulmonary toxicity were identified among 1786 patients taking amiodarone for at least 90 days from 2005 to 2015. The incidence of amiodarone pulmonary toxicity was estimated to be 1.9%. The risk factors for amiodarone pulmonary toxicity included advanced age (OR 1.047, 95% CI 1.010-1.085, p = 0.013), ventricular arrhythmia (OR 2.703, 95% CI 1.053-6.935, p = 0.039), underlying lung disease (OR 2.511, 95% CI 1.146-5.501, p = 0.021) and cumulative dose of amiodarone (OR 4.762, 95% CI 1.310-17.309 p = 0.018).ConclusionsThe incidence of amiodarone pulmonary toxicity in Chinese patients in Hong Kong is estimated to be 1.9% in this study. Age, underlying lung disease, ventricular arrhythmia and cumulative dose of amiodarone are associated with the development of amiodarone pulmonary toxicity. A prediction rule was developed to inform the risk of developing amiodarone pulmonary toxicity. | |
| dc.identifier | 10.1186/s12890-022-01926-y | |
| dc.identifier.issn | 1471-2466 | |
| dc.identifier.issn | 1471-2466 | |
| dc.identifier.uri | ||
| dc.language | eng | |
| dc.publisher | Springer Science and Business Media LLC | |
| dc.relation.ispartof | BMC pulmonary medicine | |
| dc.relation.isversionof | 10.1186/s12890-022-01926-y | |
| dc.rights.uri | ||
| dc.subject | Humans | |
| dc.subject | Lung Diseases | |
| dc.subject | Amiodarone | |
| dc.subject | Anti-Arrhythmia Agents | |
| dc.subject | Risk Factors | |
| dc.subject | Retrospective Studies | |
| dc.title | A multicenter retrospective cohort study on predicting the risk for amiodarone pulmonary toxicity. | |
| dc.type | Journal article | |
| pubs.begin-page | 128 | |
| pubs.issue | 1 | |
| pubs.organisational-group | Duke | |
| pubs.organisational-group | School of Medicine | |
| pubs.organisational-group | Basic Science Departments | |
| pubs.organisational-group | Biostatistics & Bioinformatics | |
| pubs.organisational-group | Biostatistics & Bioinformatics, Division of Biostatistics | |
| pubs.publication-status | Published | |
| pubs.volume | 22 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- A multicenter retrospective cohort study on predicting the risk for amiodarone pulmonary toxicity.pdf
- Size:
- 934.19 KB
- Format:
- Adobe Portable Document Format
- Description:
- Published version